Next generation manufacturing of the most potent compounds in pharma
You are cordially invited to join our technical symposium. ADCs and other targeted therapies are opening up a world of exciting opportunities to change the nature of cancer treatment. HPAPIs are a critical element of these therapies. Innovators are seeking to bring new treatments to market faster, more efficiently and without compromise to safety.
Date: Thursday, June 02, 2022
Time:16:30 – 19:00 CEST
Venue: Online
During this virtual event you will learn about
- Trends in HPAPI drug development and novel payloads requiring improved containment and single-ng/m³ handling capability
- Why to develop a containment strategy for single-digit nanogram OEL
- How to plan and implement a state-of the art facility for high potency API manufacturing
- New technology platforms to accelerate payload intermediate synthesis and ADC drug development programs
Organized by
